Caribou Biosciences Inc.

In News

Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Yahoo Finance - Nov 12, 2025

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma - Investing News Network

Investing News Network - Nov 02, 2025

Caribou Bio (NASDAQ: CRBU) to host Nov. 3 webcast on first CB-011 data, vispa-cel update - Stock Titan

Stock Titan - Nov 02, 2025

Caribou Biosciences: A Much Anticipated Data Readout Does Not Quite Get My Buy - Seeking Alpha

Seeking Alpha - Nov 03, 2025

Caribou Biosciences to Host Expert Panel on Access Expansion for vispa-cel CAR-T Therapy at ASH Annual Meeting - Quiver Quantitative

Quiver Quantitative - Dec 01, 2025

Caribou cuts 32% of staff, further purges pipeline to focus on 2 oncology CAR-T prospects - Fierce Biotech

Fierce Biotech - Apr 24, 2025

CRISPR PD-1 knockout allogeneic CAR-T matches autologous - CRISPR Medicine News

CRISPR Medicine News - Nov 12, 2025

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma - Investing News Network

Investing News Network - Nov 03, 2025

Caribou Biosciences to Host Webcast Reporting New Clinical Data for Anti-CD19 and Anti-BCMA CAR-T Cell Therapies - Quiver Quantitative

Quiver Quantitative - Nov 02, 2025

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies - Yahoo Finance

Yahoo Finance - Nov 03, 2025

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma - Yahoo Finance

Yahoo Finance - Nov 03, 2025

Caribou Biosciences (CRBU) Is Down 7.8% After Positive Phase 1 CAR-T Data and Phase 3 Trial Plans – Has The Bull Case Changed? - Yahoo Finance

Yahoo Finance - Nov 06, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment